Healthscape

Everything about the KOL’s in your therapeutic
area at your fingertips in HealthScape

Request a demo

Main features

World Coverage

USA

>1M people

~200k sites

Great Britain

~4k sites

France

~400k sites

Germany

~300k sites

Italy

~1.5k hospitals

Norway

~120k people

~50k organizations

Switzerland

~40k physicians

~3k sites

  • 14
    Countries
  • 3
    of the largest pharma brands
  • 1M
    more than 1,000,000 physicians

Blog

Connected Opinion Leaders (COLs): a new ally for pharma marketers

Influencer ecosystems are continually evolving in response to changing consumer preferences and the pharmaceutical sector is no exception. On one hand, patients and their doctors are looking beyond traditional Key Opinion Leaders (KOLs) for guidance on therapies and treatments and want to hear from alternative sources, such as Patient Opinion Leaders (POLs), whose feedback resonates […]

Building new capabilities into Medical Affairs

Over the past few years, physicians and other KOLs have been increasingly mindful of the time they spend with pharma sales representatives. Many of them have been reducing this time investment in favour of engaging with more scientifically knowledgeable MSL’s (Medical Science Liaisons) that can double as educators and help them stay abreast of new […]

Strategic use of digital channels for engaging with HCPs

The Covid-19 pandemic has accentuated and accelerated important changes to how healthcare providers (HCPs) keep abreast of new product information relevant to their specialties and the patients they treat. Most notable among those is the HCPs’ embrace of digital technologies and digital-first channels of delivering content. This trend is accompanied by a growing preference for […]

Moving Towards Smarter R&D vía Decentralised Clinical Trials

Finding the right number of patients with the right characteristics is one of the biggest challenges for clinical trial sponsors. In large part this is due to the fact that randomised clinical trials – the gold standard for conducting clinical research – come with rigid inclusion and exclusion criteria, which render many potential participants ineligible […]

KOLs, POLs, and DOLs: Expanding the universe of opinion leaders

Two converging and consolidating trends – the amplification of the digital space (social media, messaging apps, microblogs, short video apps, and Q&A destinations such as Reddit and Quora) and patient-centred transformation – are driving largescale shifts in value creation in the pharmaceutical and biotech industry. As such, going digital and listening to the patient voice […]